<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 2004, a teenager survived bat-associated <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> through the Milwaukee protocol (MP) </plain></SENT>
<SENT sid="1" pm="."><plain>This survivor and another patient with dog-associated <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> were found to have developed deficiencies of tetrahydrobiopterin (<z:chebi fb="5" ids="30157">BH4</z:chebi>) and associated <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="30157">BH4</z:chebi> is also essential for neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS), so <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> is predicted to cause constriction of cerebral arteries </plain></SENT>
<SENT sid="3" pm="."><plain>We assume that <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> virus, which almost exclusively targets neurons, would disproportionately affect cerebral over systemic perfusion by disrupting nNOS and lead to generalised <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral artery spasm</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Cranial artery vasospasm, therefore, was actively sought in two <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> patients, with the intention to specifically treat with <z:chebi fb="5" ids="30157">BH4</z:chebi> and <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> when necessary </plain></SENT>
<SENT sid="5" pm="."><plain>Flow velocities and resistive (RI) or pulsatility indices (PI) of middle cerebral arteries (<z:chebi fb="70" ids="34342">MCA</z:chebi>) were obtained by transcranial doppler ultrasound (TCD) </plain></SENT>
<SENT sid="6" pm="."><plain>A survival analysis of 8 attempts at the MP is presented </plain></SENT>
<SENT sid="7" pm="."><plain>Of these, two cases are reported here </plain></SENT>
<SENT sid="8" pm="."><plain>The first case is one child with bat-associated <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> who developed severe bilateral MCAspasm on hospital day (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>)-10 that responded to very low dose (0.2 mcg/kg/min) <z:chebi fb="0" ids="7596">nitroprusside</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The second case, a child with dog-associated <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e>, developed spasm of <z:chebi fb="70" ids="34342">MCA</z:chebi> on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-6 that responded to 6 mg/kg/day <z:chebi fb="5" ids="30157">BH4 </z:chebi></plain></SENT>
<SENT sid="10" pm="."><plain>A second spasm with high RI (without cerebral <z:hpo ids='HP_0000969'>oedema</z:hpo> or <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo>) responded to 20 mg/kg/day <z:chebi fb="5" ids="30157">BH4</z:chebi> and 0.5 g/kg/dose <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>Review of the TCD of the first child showed a similar second spasm seven days after first episode </plain></SENT>
<SENT sid="12" pm="."><plain>Cerebral artery vasospasm occurred in the two children with <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e>, but was clinically silent by standard monitoring </plain></SENT>
<SENT sid="13" pm="."><plain>Spasm responded to drugs directed at the NOS pathway </plain></SENT>
<SENT sid="14" pm="."><plain>Animal models for treatment of <z:e sem="disease" ids="C0034494" disease_type="Disease or Syndrome" abbrv="">rabies</z:e> are sorely needed to evaluate therapy </plain></SENT>
</text></document>